CONMED Corporation (CNMD) |
| 40.03 -3.43 (-7.89%) 01-13 16:00 |
| Open: | 43.53 |
| High: | 43.68 |
| Low: | 39.6 |
| Volume: | 579,156 |
| Market Cap: | 1,240(M) |
| PE Ratio: | 19.53 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 45.69 |
| Resistance 1: | 42.87 |
| Pivot price: | 41.58 |
| Support 1: | 38.32 |
| Support 2: | 31.88 |
| 52w High: | 74.7 |
| 52w Low: | 38.32 |
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
| EPS | 2.050 |
| Book Value | 32.570 |
| PEG Ratio | 0.00 |
| Gross Profit | 24.576 |
| Profit Margin (%) | 4.76 |
| Operating Margin (%) | 10.84 |
| Return on Assets (ttm) | 4.2 |
| Return on Equity (ttm) | 6.6 |
Tue, 13 Jan 2026
SG Americas Securities LLC Acquires 61,860 Shares of CONMED Corporation $CNMD - MarketBeat
Mon, 12 Jan 2026
CONMED Highlights Growth Outlook at J.P. Morgan Conference - TipRanks
Mon, 12 Jan 2026
Conmed Corp - Prelim Outlook FY 2026 Total Reported Revenue $1,345 Million To $1,375 Million - Presentation - TradingView — Track All Markets
Mon, 12 Jan 2026
3 Reasons to Sell CNMD and 1 Stock to Buy Instead - Finviz
Sun, 11 Jan 2026
Peregrine Capital Management LLC Has $58,000 Stake in CONMED Corporation $CNMD - MarketBeat
Fri, 09 Jan 2026
A Look At CONMED (CNMD) Valuation After CFO Transition Plans And 2025 Guidance Reaffirmation - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |